Wall Street analysts expect Varian Medical Systems, Inc. (NYSE:VAR) to post earnings per share of $1.19 for the current quarter, according to Zacks. Four analysts have issued estimates for Varian Medical Systems’ earnings, with the highest EPS estimate coming in at $1.20 and the lowest estimate coming in at $1.17. Varian Medical Systems posted earnings of $1.38 per share in the same quarter last year, which suggests a negative year over year growth rate of 13.8%. The firm is expected to announce its next earnings report after the market closes on Wednesday, October 25th.

According to Zacks, analysts expect that Varian Medical Systems will report full-year earnings of $3.96 per share for the current financial year, with EPS estimates ranging from $3.76 to $4.04. For the next financial year, analysts expect that the company will post earnings of $4.38 per share, with EPS estimates ranging from $4.28 to $4.55. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of research analysts that follow Varian Medical Systems.

Varian Medical Systems (NYSE:VAR) last announced its quarterly earnings results on Wednesday, July 26th. The medical equipment provider reported $1.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.95 by $0.09. Varian Medical Systems had a return on equity of 24.70% and a net margin of 9.50%. The business had revenue of $662.40 million during the quarter, compared to the consensus estimate of $663.86 million. During the same quarter last year, the firm posted $1.00 EPS. The company’s quarterly revenue was up 3.0% on a year-over-year basis.

A number of research analysts have recently commented on the company. BidaskClub raised Varian Medical Systems from a “buy” rating to a “strong-buy” rating in a research note on Thursday, June 22nd. Aegis reaffirmed a “hold” rating and set a $91.00 target price on shares of Varian Medical Systems in a research note on Wednesday, May 17th. BTIG Research cut Varian Medical Systems from a “buy” rating to a “neutral” rating in a research note on Thursday, September 7th. They noted that the move was a valuation call. Robert W. Baird reaffirmed a “neutral” rating and set a $99.00 target price (up previously from $89.00) on shares of Varian Medical Systems in a research note on Friday, July 14th. Finally, Zacks Investment Research cut Varian Medical Systems from a “buy” rating to a “hold” rating in a research note on Thursday, July 13th. Two research analysts have rated the stock with a sell rating, eight have given a hold rating and two have issued a buy rating to the stock. Varian Medical Systems has a consensus rating of “Hold” and an average price target of $97.39.

In related news, EVP Kolleen T. Kennedy sold 26,092 shares of the business’s stock in a transaction that occurred on Tuesday, June 20th. The stock was sold at an average price of $105.00, for a total value of $2,739,660.00. Following the completion of the sale, the executive vice president now owns 52,692 shares in the company, valued at $5,532,660. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Dow R. Wilson sold 15,060 shares of the business’s stock in a transaction that occurred on Monday, July 10th. The shares were sold at an average price of $103.37, for a total value of $1,556,752.20. Following the completion of the sale, the insider now owns 81,836 shares of the company’s stock, valued at approximately $8,459,387.32. The disclosure for this sale can be found here. Insiders sold 79,946 shares of company stock valued at $8,240,015 in the last quarter. 0.91% of the stock is owned by company insiders.

A number of institutional investors have recently bought and sold shares of VAR. Profund Advisors LLC lifted its holdings in Varian Medical Systems by 14.4% during the first quarter. Profund Advisors LLC now owns 3,866 shares of the medical equipment provider’s stock worth $352,000 after buying an additional 487 shares during the period. ProShare Advisors LLC lifted its holdings in Varian Medical Systems by 1.2% during the first quarter. ProShare Advisors LLC now owns 9,396 shares of the medical equipment provider’s stock worth $856,000 after buying an additional 115 shares during the period. First Mercantile Trust Co. lifted its holdings in Varian Medical Systems by 2.3% during the first quarter. First Mercantile Trust Co. now owns 1,093 shares of the medical equipment provider’s stock worth $100,000 after buying an additional 25 shares during the period. Daiwa Securities Group Inc. lifted its holdings in Varian Medical Systems by 12.0% during the first quarter. Daiwa Securities Group Inc. now owns 2,800 shares of the medical equipment provider’s stock worth $255,000 after buying an additional 300 shares during the period. Finally, Suntrust Banks Inc. lifted its holdings in Varian Medical Systems by 23.0% during the first quarter. Suntrust Banks Inc. now owns 9,983 shares of the medical equipment provider’s stock worth $907,000 after buying an additional 1,864 shares during the period. Institutional investors own 99.64% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This piece was published by American Banking News and is the sole property of of American Banking News. If you are viewing this piece on another domain, it was illegally copied and reposted in violation of United States & international copyright law. The legal version of this piece can be accessed at https://www.americanbankingnews.com/2017/09/14/varian-medical-systems-inc-var-expected-to-post-earnings-of-1-19-per-share.html.

Shares of Varian Medical Systems (NYSE:VAR) opened at 107.68 on Thursday. Varian Medical Systems has a one year low of $75.20 and a one year high of $107.80. The firm has a market cap of $9.89 billion, a P/E ratio of 35.44 and a beta of 0.58. The firm’s 50-day moving average price is $101.14 and its 200 day moving average price is $97.06.

Varian Medical Systems Company Profile

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Get a free copy of the Zacks research report on Varian Medical Systems (VAR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.